Paris
France
3
2025-05-15
2
2026-05-19
These are the the leading inventors for applications assigned to Acticor Biotech:
Acticor Biotech based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TREATMENT OF CARDIOVASCULAR DISEASES USING ANTI-HUMAN GPVI ANTIBODIES
#2 | 2023-12-07 ✅ Patent 12,630,631 granted on 2026-05-19INHIBITION OF PLATELET AGGREGATION USING ANTI-HUMAN GPVI ANTIBODIES
#3 | 2019-12-05 ✅ Patent 11,692,033 granted on 2023-07-04Inhibition of platelet aggregation using anti-human GPVI antibodies
Also check out ACTICOR BIOTECH's (Paris, France) applicant profile with 4 patent applications submitted.
601227 ⎘